Having trouble viewing the email? click here.

We hope 2018 has started as it should for all of you. We sent out our “Happy New Year” wishes a while ago and are now busy with the current portfolio, new applications, our annual innovation contest and much more.


Since the previous edition covered our 4 new portfolio companies, we will use this edition of the eHV newsletter to provide a more generalist view (on topics such as Regulation, Academia, Accelerators, Industry etc.).


Enjoy.

The eHealth Ventures Team

As of January 2018, each new eHV Company will be eligible for a 3 M NIS Investment (instead of the current 2.5 M)
This recent amendment in the Israeli Innovation Authority (IIA) policy is directed only towards “rural” incubators such as eHealth Ventures and their portfolio companies. According to Anya Eldan, VP of the IIA and head of the Start-Up division, rural areas in Israel are rich in entrepreneurship activity but lacking investment capability. By applying this change, the IIA hopes to attract entrepreneurs to the rural-based incubators.

For the PR (in Hebrew) – please visit here
eHV to Partner with Leading Academic Institutes for Horizon 2020 Grant
We have recently entered a consortium of 5 leading research institutions across Europe (Italy, Netherlands, France). This will allow eHV access to a top-notch European network (academic institutions and SME’s) and can also serve as a launching pad for future European grants or collaborations.

eHealth Ventures will also be featured on the ITN website, and receive an internship for 3-4 months by foreign Ph.D. student, which will enable ties with organizations in the student’s country of origin. For instance, if the ESR (Early Stage Researcher) comes from the Netherlands, by being part of the ITN, eHealth Ventures will be connected to the Dutch landscape of eHealth SMEs and funding bodies, hopefully leading to new business models and alternatives to fundraising.
eHealth Ventures 2nd Innovation Contest - Deadline Update
We have over 20 candidates and have decided to extend the deadline for application to Feb 15th, 2018 at 12:00 PM.

Just Do It - Send an Application!
Our friends at Mass Challenge Israel (MCI) are announcing a call for a new “batch” for the leading Accelerators in Israel
The applicants that will be accepted will get close guidance in accessing the multinational Medical Device market, including a network of over 100 leading corporations which are affiliated with the MCI accelerator, and an A-list of top mentors. The 10 outstanding graduates will participate in a fully funded delegation to the US in order to network and partner with the MCI ecosystem of partners in NY and Boston.

Application is online at: http://bit.ly/2CDVEpV
Digital Health News: for the first time, the FDA has approved a digital pill: medication embedded with a sensor that can tell doctors whether, and when, patients take their medicine
The approval, announced last November, marks a significant advance in the growing field of digital devices designed to monitor medicine-taking and to address the expensive, longstanding problem that millions of patients do not take drugs as prescribed. Experts estimate that so-called nonadherence or noncompliance to medication costs about $100 billion a year, much of it because patients get sicker and need additional treatment or hospitalization.

This is how the MYCITE system works:
  • The first FDA-approved digital medicine system, is comprised of a tablet embedded at the point of manufacture with an IEM sensor. This IEM sensor is the size of a grain of sand, and is made up of ingredients found in food.
  • The IEM sensor activates when in contact with stomach fluid and communicates to a wearable sensor, called the MYCITE Patch. The IEM sensor is then digested and eliminated from the body.
  • The MYCITE Patch detects and records the date and time of the ingestion of the tablet, as well as, certain physiological data such as activity level, and communicates this and the tablet ingestion data to the MYCITE APP on a compatible mobile device.
  • The MYCITE APP allows individuals to review their objective medication ingestion and daily activity level, as well as enter their mood and rest. They can also invite others to view their data.
For more information click here.
Quote of the week
“If you are not embarrassed by the first version of your product, you’ve launched too late.”

- Reid Hoffman, co-founder and executive chairman of LinkedIn


Notable Interview
This is an interview with Jonathan Adiri - founder and CEO of Health.IO, which recently raised $ 12 M. I must admit the headline is simplistic, but the article tells a solid story of success (in Hebrew…)

“Take a Selfie and send it to your Physician… The startup that will save you a visit to the clinic.

Jonathan Adiri’s new venture aspires to revolutionize that way we access healthcare. The Economist calls it – “The Company who introduced the ‘Medical Selfie’, and Adiri admits – we are building a medical company on “pop culture” standards.”

See the full interview here (Hebrew)
 
To change your subscription, click here.